ISIN | CH0445993279 |
---|---|
Valor Number | 44599327 |
Bloomberg Global ID | |
Fund Name | Unigestion Swiss Equities R |
Fund Provider |
Unigestion
Genève 12, Switzerland Phone: +41 22 704 41 11 Web: www.unigestion.com |
Fund Provider | Unigestion |
Representative in Switzerland | |
Distributor(s) |
Unigestion S.A. Genève 12 Phone: +41 22 704 41 11 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | The main objective of the fund is to achieve a long term performance equal to,or greater than,the SMI index,with a lower volatility while controlling the tracking error of the portfolio.This is achieved by using a quantitative method based on the construction of a "minimum variance" portfolio,i.e. the optimal portfolio having the lowest expected volatility or risk. |
Peculiarities |
Current Price * | 133.21 CHF | 26.09.2024 |
---|---|---|
Previous Price * | 132.77 CHF | 25.09.2024 |
52 Week High * | 134.09 CHF | 02.09.2024 |
52 Week Low * | 116.26 CHF | 23.10.2023 |
NAV * | 133.21 CHF | 26.09.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 82,469,424 | |
Unit/Share Assets *** | 2,969,961 | |
Trading Information SIX |
YTD Performance | +10.13% |
29.12.2023 - 26.09.2024
29.12.2023 26.09.2024 |
---|---|---|
1 month | +0.07% |
26.08.2024 - 26.09.2024
26.08.2024 26.09.2024 |
3 months | +2.90% |
26.06.2024 - 26.09.2024
26.06.2024 26.09.2024 |
6 months | +6.54% |
26.03.2024 - 26.09.2024
26.03.2024 26.09.2024 |
1 year | +10.02% |
26.09.2023 - 26.09.2024
26.09.2023 26.09.2024 |
2 years | +17.95% |
26.09.2022 - 26.09.2024
26.09.2022 26.09.2024 |
3 years | +4.56% |
28.09.2021 - 26.09.2024
28.09.2021 26.09.2024 |
5 years | +20.34% |
26.09.2019 - 26.09.2024
26.09.2019 26.09.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 11.88% | |
---|---|---|
Roche Holding AG | 9.84% | |
Nestle SA | 8.16% | |
Zurich Insurance Group AG | 7.46% | |
Swiss Re AG | 4.79% | |
ABB Ltd | 4.68% | |
Swiss Life Holding AG | 4.07% | |
Swisscom AG | 3.77% | |
Swiss Prime Site AG | 3.30% | |
Galenica Ltd. | 3.19% | |
Last data update | 31.07.2024 |
TER | 1.06% |
---|---|
TER date | 31.03.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | 1.06% |
SRRI ***
|
|
SRRI date *** | 31.08.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |